SPONSORED GUEST ARTICLE]  [SPONSORED GUEST ARTICLE]  The big generative AI bang of November 2022 -- OpenAI’s release of ...

The Centers for Medicare and Medicaid Services is directing all Medicare Advantage plans to cover Qalsody for treating ...

ABOVE: Scientists are exploring the relationship between the expression of ancient viral DNA and neurodegenerative disease ...

A new study from the Institute of Environmental Medicine (IMM), published in The Lancet Regional Health - Europe, shows that ...

Neurologists have grappled with a cluster of amyotrophic lateral sclerosis cases in France, where a fondness for a toxic wild ...

Dazucorilant failed to slow disease progression in ALS patients in the DAZALS Phase 2 clinical trial, but may have extended ...

A new meta-analysis suggests that active exercise may slow functional decline in ALS, while noninvasive brain stimulation ...

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer's disease has been licenced to ...

Here is a look at the 10 most prominent lateral lawyer moves of 2024, compiled with input from a handful of legal industry ...

Neurizon has reported positive eight-month interim data from its open-label extension study in patients with ALS (motor ...

In the 60+ years that it's been on the air, the daytime ABC drama "General Hospital" has brought attention to an array of ...